Paratek Pharmaceuticals Inc.

NASDAQ:PRTK  
2.13
-0.01 (-0.47%)
4:18:48 PM EDT: $2.11 -0.02 (-0.94%)
Products

Paratek's Nuzyra Receives FDA Fast Track Designation For Treatment Of Pulmonary Nontuberculous Mycobacterial Disease

Published: 06/21/2022 20:32 GMT
Paratek Pharmaceuticals Inc. (PRTK) - Paratek Pharmaceuticals’ Nuzyra® Receives FDA Fast Track Designation for the Treatment of Pulmonary Nontuberculous Mycobacterial (ntm) Disease Caused by Mycobacterium Avium Complex (mac) and Mycobacterium Abscessus (mab).